Changing Management of Clinical Low-Stage Testicular Cancer
Stage I and II testicular germ cell tumors (GCTs) are almost always cured with appropriate treatment and most ongoing research regarding these tumors focuses on minimizing treatment toxicity. The management of clinical stage I testicular GCTs has grown more complicated due to the emergence of a brie...
Main Author: | Timothy Gilligan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2005-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2005.97 |
Similar Items
-
Management of poor-prognosis testicular germ cell tumors
by: Kiranpreet Khurana, et al.
Published: (2010-01-01) -
Evaluating the Effect of Cryptorchidism on Clinical Stage of Testicular Seminoma
by: Wang X, et al.
Published: (2020-06-01) -
The Management of Nonseminomatous Testicular Cancer
by: Graeme S. Steele, et al.
Published: (2004-01-01) -
Risk-adapted treatment reduced chemotherapy exposure for clinical stage I pediatric testicular cancer
by: Yun-lin Ye, et al.
Published: (2020-12-01) -
Cost analysis of adjuvant management strategies in early stage (stage I) testicular seminoma
by: Cox JA, et al.
Published: (2015-01-01)